Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) [Phase 1]

View source ↗

Summary

A Phase I clinical trial update for an absorbed acellular pertussis–diphtheria–tetanus vaccine intended for adults and adolescents; the study is currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (Adults and Adolescents) (Absorbed acellular pertussis-diphtheria-tetanus vaccine (two-component))

Snippet

Sponsor: Changchun BCHT Biotechnology Co. | Conditions: Pertussis (Whooping Cough), Diphtheria | Phase 1 | Status: NOT_YET_RECRUITING